CTT PHARMACEUTICAL HOLDINGS, INC. - 10-Q Filing
CTT Pharmaceutical Holdings reports $127,064 net loss for Q3 2026 with zero revenue-producing activities.
Tickers: $CTTH
Read the full article at SEC EDGAR
Part of the story Avalyn Pharma Inc. - 10-Q Filing (10 articles)